UAS Tri-Axis Dominant-Primary Series IV-IV

Solanum lycopersicum

Tomato

Tier IVUAS Tri-Axis Dominant-Primary Series

Target Trait

2.38×

fold-change

Umami-dominant tri-axis A+S modulated fold-change

Technical Specifications

SKU

SS-F-M3-02344

Genomic Edits

GC Content

44.3%

Construct Length

6,264 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro cell-free

Host Strain

Cell-free

Receptor Target

mGluR1 + Polyphenol-astringency axis + TAS1R2/TAS1R3

IFI Score

238

Pathway Edits

mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
Polyphenol-astringency axis pathway primary gene cluster for astringency (IFI-A) tri-axis component
TAS1R2/TAS1R3 pathway primary gene cluster for sweet (IFI-S) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent UAS pathway operation
Cross-pathway regulatory circuit for umami-dominant UAS triple-axis expression
Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: mGluR1, Polyphenol-astringency axis, and TAS1R2/TAS1R3 pathways simultaneously engineeredUmami-dominant tri-axis expression strategy (UAS) with cross-pathway flux managementCell-free co-translation of multi-axis enzyme sets for in-vitro biochemical validation

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier IV UAS triple-axis construct for advanced multi-modal sensory architecture combining umami, astringency, and sweet axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$3999 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities